Brite |
KEGG Orthology (KO) [BR:ko00001]
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
04630 JAK-STAT signaling pathway
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
04066 HIF-1 signaling pathway
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
04068 FoxO signaling pathway
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
04151 PI3K-Akt signaling pathway
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
09140 Cellular Processes
09143 Cell growth and death
04110 Cell cycle
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
04115 p53 signaling pathway
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
04218 Cellular senescence
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
09150 Organismal Systems
09152 Endocrine system
04921 Oxytocin signaling pathway
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
04928 Parathyroid hormone synthesis, secretion and action
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05202 Transcriptional misregulation in cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05206 MicroRNAs in cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05205 Proteoglycans in cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05203 Viral carcinogenesis
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
09162 Cancer: specific types
05210 Colorectal cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05212 Pancreatic cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05225 Hepatocellular carcinoma
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05226 Gastric cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05214 Glioma
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05216 Thyroid cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05220 Chronic myeloid leukemia
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05217 Basal cell carcinoma
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05218 Melanoma
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05211 Renal cell carcinoma
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05219 Bladder cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05215 Prostate cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05213 Endometrial cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05224 Breast cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05222 Small cell lung cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05223 Non-small cell lung cancer
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05161 Hepatitis B
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05160 Hepatitis C
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05163 Human cytomegalovirus infection
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05167 Kaposi sarcoma-associated herpesvirus infection
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05169 Epstein-Barr virus infection
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
05165 Human papillomavirus infection
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
09167 Endocrine and metabolic disease
04934 Cushing syndrome
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
01522 Endocrine resistance
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
|